Mitochondrial DNA variation is associated with elite athletic status in the Polish population

Scandinavian Journal of Medicine and Science in Sports

Volumn 24, Issue 2, 2014, Pages 311-318

  Maruszak, A ^a   Adamczyk, J G ^b,c   Siewierski, M ^b   Sozanski H ^b   Gajewski, A ^b   Zekanowski, C ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b JÓZEF PI SUDSKI UNIVERSITY OF PHYSICAL EDUCATION IN WARSAW   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Endurance athletes; Genetics; Haplogroup; Mitochondria; mtDNA; Polymorphisms; Power athletes

Indexed keywords

DNA BINDING PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PPARGC1A PROTEIN, HUMAN; TFAM PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; ATHLETIC PERFORMANCE; CASE CONTROL STUDY; CAUCASIAN; CELL NUCLEUS; ENDURANCE; ENDURANCE ATHLETES; FEMALE; GENETICS; HAPLOGROUP; HAPLOTYPE; HUMAN; MALE; MITOCHONDRION; MUSCLE STRENGTH; PHYSIOLOGY; POLAND; POLYMORPHISMS; POWER ATHLETES; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE;

ENDURANCE ATHLETES; GENETICS; HAPLOGROUP; MITOCHONDRIA; MTDNA; POLYMORPHISMS; POWER ATHLETES;

ATHLETIC PERFORMANCE; CASE-CONTROL STUDIES; CELL NUCLEUS; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HUMANS; MALE; MITOCHONDRIAL PROTEINS; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 84896395980     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/sms.12012     Document Type: Article

References (35)

1. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem 2010: 285: 21590-21599.
2. Arning L, Haghikia A, Taherzadeh-Fard E, Saft C, Andrich J, Pula B, Höxtermann S, Wieczorek S, Akkad DA, Perrech M, Gold R, Epplen JT, Chan A. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J Mol Med 2010: 88: 431-436.
3. Calvo JA, Daniels TG, Wang X, Paul A, Lin J, Spiegelman BM, Stevenson SC, Rangwala SM. Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake. J Appl Physiol 2008: 104: 1304-1312.
4. Castro MG, Terrados N, Reguero JR, Alvarez V, Coto E. Mitochondrial haplogroup T is negatively associated with the status of elite endurance athlete. Mitochondrion 2007: 7: 354-357.
5. Chang Y, Yu CL, Gao XL, Liu AJ. Polymorphisms in the mtDNA hypervariable region related to individual differences in endurance performance. Mitochondrial Physiology Network 2005: 10.9: 1-152, 1-08.
6. Cross DS, Ivacic LC, Stefanski EL, McCarty CA. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. BMC Genet 2010: 11: 51.
7. Dionne FT, Turcotte L, Thibault MC, Boulay MR, Skinner JS, Bouchard C. Mitochondrial DNA sequence polymorphism, VO2max, and response to endurance training. Med Sci Sports Exerc 1991: 23: 177-185.
8. Eynon N, Meckel Y, Sagiv M, Yamin C, Amir R, Sagiv M, Goldhammer E, Duarte JA, Oliveira J. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scand J Med Sci Sports 2010: 20: e145-e150.
9. Eynon N, Ruiz JR, Oliveira J, Duarte JA, Birk R, Lucia A. Genes and elite athletes: a roadmap for future research. J Physiol 2011a: 589 (Pt 13): 3063-3070.
10. Eynon N, Morán M, Birk R, Lucia A. The champions' mitochondria: is it genetically determined? A review on mitochondrial DNA and elite athletic performance. Physiol Genomics 2011b: 43: 789-798.
11. Eynon N, Birk R, Meckel Y, Lucia A, Nemet D, Eliakim A. Physiological variables and mitochondrial-related genotypes of an athlete who excels in both short and long-distance running. Mitochondrion 2011c: 11: 774-777.
12. He Z, Hu Y, Feng L, Bao D, Wang L, Li Y, Wang J, Liu G, Xi Y, Wen L, Lucia A. Is there an association between PPARGC1A genotypes and endurance capacity in Chinese men? Scand J Med Sci Sports 2008: 18: 195-204.
13. Hedrick P, Kumar S. Mutation and linkage disequilibrium in human mtDNA. Eur J Hum Genet 2001: 9: 969-972.
14. Kang D, Kim SH, Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 2007: 7: 39-44.
15. Kanki T, Ohgaki K, Gaspari M, Gustafsson CM, Fukuoh A, Sasaki N, Hamasaki N, Kang D. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol Cell Biol 2004: 24: 9823-9834.
16. Kuno S, Zempo H, Murakami H. Mitochondrial DNA sequence variation and performance. In: Bouchard C, Hoffman EP, eds. Genetic and molecular aspects of sport performance. Chichester: John Wiley & Sons, 2011: 215-226.
17. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007: 80: 531-538.
18. Lucia A, Gómez-Gallego F, Barroso I, Rabadán M, Bandrés F, San Juan AF, Chicharro JL, Ekelund U, Brage S, Earnest CP, Wareham NJ, Franks PW. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol 2005: 99: 344-348.
19. Maciejewska A, Sawczuk M, Cieszczyk P, Mozhayskaya IA, Ahmetov II. The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J Sports Sci 2012: 30: 101-113.
20. Martínez-Redondo D, Marcuello A, Casajús JA, Ara I, Dahmani Y, Montoya J, Ruiz-Pesini E, López-Pérez MJ, Díez-Sánchez C. Human mitochondrial haplogroup H: the highest VO2max consumer - is it a paradox? Mitochondrion 2010: 10: 102-107.
21. Maruszak A, Canter JA, Styczyńska M, Zekanowski C, Barcikowska M. Mitochondrial haplogroup H and Alzheimer's disease - is there a connection? Neurobiol Aging 2009: 30: 1749-1755.
22. Maruszak A, Safranow K, Branicki W, Gaweda-Walerych K, Pośpiech E, Gabryelewicz T, Canter JA, Barcikowska M, Zekanowski C. The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk. J Alzheimers Dis 2011: 27: 197-210.
23. Mikami E, Fuku N, Takahashi H, Ohiwa N, Pitsiladis YP, Higuchi M, Kawahara T, Tanaka M. Polymorphisms in the control region of mitochondrial DNA associated with elite Japanese athlete status. Scand J Med Sci Sports 2013: 23: 593-599.
24. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003: 56: 73-82.
25. Murakami H, Ota A, Simojo H, Okada M, Ajisaka R, Kuno S. Polymorphisms in control region of mtDNA relates to individual differences in endurance capacity or trainability. Jpn J Physiol 2002: 52: 247-256.
26. Niemi AK, Majamma K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 2005: 13: 965-969.
27. Nogales-Gadea G, Pinós T, Ruiz JR, Marzo PF, Fiuza-Luces C, López-Gallardo E, Ruiz-Pesini E, Martín MA, Arenas J, Morán M, Andreu AL, Lucia A. Are mitochondrial haplogroups associated with elite athletic status? A study on a Spanish cohort. Mitochondrion 2011: 11: 905-908.
28. Norrbom J, Wallman SE, Gustafsson T, Rundqvist H, Jansson E, Sundberg CJ. Training response of mitochondrial transcription factors in human skeletal muscle. Acta Physiol (Oxf) 2010: 198: 71-79.
29. Peeters MW, Thomis MA, Beunen GP, Malina RM. Genetics and sports: an overview of the pre-molecular biology era. Med Sport Sci 2009: 54: 28-42.
30. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, Tarnopolsky MA. Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem 2011: 286: 10605-10617.
31. Stumvoll M, Fritsche A, t'Hart LM, Machann J, Thamer C, Tschritter O, Van Haeften TW, Jacob S, Dekker JM, Maassen JA, Machicao F, Schick F, Heine RJ, Häring H. The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Exp Clin Endocrinol Diabetes 2004: 112: 253-257.
32. Vainshtein A, Kazak L, Hood DA. Effects of endurance training on apoptotic susceptibility in striated muscle. J Appl Physiol 2011: 110: 1638-1645.
33. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005: 39: 359-407.
34. Wallace DC. Bioenergetics, the origins of complexity, and the ascent of man. Proc Natl Acad Sci USA 2010: 107: 8947-8953.
35. Wallace DC. Mitochondrial medicine in health and disease: interface between athletic performance and therapeutics. In: Bouchard C, Hoffman EP, eds. Genetic and molecular aspects of sport performance. Chichester: Blackwell Publ Ltd, 2011: 14-32.